Skip to main content
Top

Open Access 18-03-2024 | Obesity | Original Article

Early age at menarche and the risk of gestational diabetes mellitus: a cohort study

Authors: Anastasia Angelopoulou, Kleoniki I. Athanasiadou, Maria Zairi, Evangelia Zapanti, Vasiliki Vasileiou, Stavroula A. Paschou, Eleni Anastasiou

Published in: Endocrine

Login to get access

Abstract

Purpose

To evaluate whether there is an association between age at menarche (AAM) and the risk of gestational diabetes mellitus (GDM).

Methods

A retrospective cohort study was conducted, including 5390 pregnant women who were screened for GDM at Alexandra Hospital in Athens, Greece over a 15-year period (2000–2014). Maternal age, pre-pregnancy body mass index (BMI), height, family history of type 2 diabetes mellitus, parity, educational and smoking status, and AAM were recorded. The results were expressed as odds ratios (OR) with a 95% confidence interval (95% CI).

Results

Pregnant women with GDM experienced earlier menarche compared to normoglycemic women (12.9 ± 1.5 vs 13.1 ± 1.6, p < 0.001, respectively). The OR for a woman with AAM <12 years to develop GDM was 1.08 (95% CI 1.03–1.14), while the OR to be obese was 1.70 (95% CI 1.50–1.90). The multivariate logistic regression analysis showed that AAM is a risk factor for GDM. However, that effect was lost after adjusting for BMI.

Conclusion

Early AAM may be associated with an increased risk of GDM. Therefore, it can be used to identify high-risk women and implement preconception interventions for GDM prevention. Future studies should be conducted to confirm these findings.
Literature
9.
go back to reference J.R. Roy, S. Chakraborty, T.R. Chakraborty, Estrogen-like endocrine disrupting chemicals affecting puberty in humans - a review. Med. Sci. Monit. 15, 137–145 (2009). J.R. Roy, S. Chakraborty, T.R. Chakraborty, Estrogen-like endocrine disrupting chemicals affecting puberty in humans - a review. Med. Sci. Monit. 15, 137–145 (2009).
11.
go back to reference N.T. Mueller, B.B. Duncan, S.M. Barreto, D. Chor, M. Bessel, E.M.L. Aquino et al. Earlier age at menarche is associated with higher diabetes risk and cardiometabolic disease risk factors in Brazilian adults: Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Cardiovasc. Diabetol. 13, 1–8 (2014). https://doi.org/10.1186/1475-2840-13-22CrossRef N.T. Mueller, B.B. Duncan, S.M. Barreto, D. Chor, M. Bessel, E.M.L. Aquino et al. Earlier age at menarche is associated with higher diabetes risk and cardiometabolic disease risk factors in Brazilian adults: Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Cardiovasc. Diabetol. 13, 1–8 (2014). https://​doi.​org/​10.​1186/​1475-2840-13-22CrossRef
Metadata
Title
Early age at menarche and the risk of gestational diabetes mellitus: a cohort study
Authors
Anastasia Angelopoulou
Kleoniki I. Athanasiadou
Maria Zairi
Evangelia Zapanti
Vasiliki Vasileiou
Stavroula A. Paschou
Eleni Anastasiou
Publication date
18-03-2024
Publisher
Springer US
Published in
Endocrine
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-024-03776-6
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.